At In-Cosmetics 2012, the Solabia Group will introduce new technology for the skin ecosystem, including: a bacterial adhesion regulator, an extracellular matrix (ECM) density booster and new research on a sirtuin activator for decreased skin sensitivity.
Teflose (INCI: Propanediol (and) Water (aqua) (and) Rhamnose (and) Glucose (and) Glucuronic Acid) inhibits the adhesion of undesirable or pathogenic bacterial strains involved in body odors, acne and sensitive skin types such as atopic dermatitis. The active is a rhamnose-rich, natural branched polysaccharide obtained by bacterial fermentation. It serves as an anti-adhesive protective cover. It also helps modulate the resultant inflammatory response generated by microbial stress and decrease the feeling of discomfort.
Unlike antibacterial products commonly used in the cosmetic industry, this alternative strategy presents a particular interest for the cutaneous ecosystem as well as the skin’s natural defenses such as the microbial saprophytic flora. The active is approved by Ecocert and for use in China.
Viniderm (INCI: Propanediol (and) Water (aqua) (and) Vitis Vinifera Grape Juice Extract) is an anti-aging active that boosts density in the ECM. It is produced through the bioconversion of resveratrol into delta-viniferin. The resveratrol is sourced from grapes found in Languedoc Roussillon. The bioconversion process obtains a higher antioxidant concentration that naturally found on the vine.
Delta-viniferin is said to have to anti-aging functions. It preserves the skin’s youthfulness by protecting stem cell niches and mitochondrial DNA. Also, it reduces the signs of aging by redensifying the ECM. The active is approved by Ecocert and for use in China.
The company has conducted new research on its moisturizing and sensory ingredient Fucogel (INCI: Biosaccharide Gum-1), which has been shown to serve as an anti-inflammatory by activating siruin-1. This active intervenes in immunomodulation and inflammation regulation through sirtuins and fucose receptors in the keratinocytes, suggesting a new treatment for sensitive skin.